NewsBenzinga이뮤노움, ESMO 2026에서 데스모이드 종양에 대한 바레가세스타트의 프로파일을 뒷받침하는 새로운 임상 분석 결과 발표 이뮤노움, ESMO 2026에서 데스모이드 종양에 대한 바레가세스타트의 프로파일을 뒷받침하는 새로운 임상 분석 결과 발표 Benzinga 2026.10.26 11:10 (GMT+0) Open on Benzinga Other news Arthur Hayes: Bullish on ETH, ZEC, NEAR and VVV, Has Built Small- and Mid-Sized Positions Huang's Nvidia Return Odds Rebound to 11% on Kalshi Hackers Spread Crypto-Stealing Trojan via Fake GTA 6 PC Download Links Invesco's Stablecoin Reserve Fund Goes Live on Ethereum 7 Major US Banks Disclose XRP ETF Holdings in SEC Filings, Totaling About $29.4M Anthropic Requires Employees to Set Written Plans 30 Days in Advance to Sell Shares, to Prevent Insider Trading
Anthropic Requires Employees to Set Written Plans 30 Days in Advance to Sell Shares, to Prevent Insider Trading